Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 380,801 | 0 | N/A | 4,533,000 | 3,302,000 |
| Marketable Securities | N/A | 0 | N/A | 1,665,000 | 1,461,000 |
| Receivables | 21,906 | 0 | N/A | 1,941,000 | 1,766,000 |
| Inventories | 2,736 | 0 | N/A | 1,299,000 | 1,493,000 |
| Income taxes - deferred | N/A | N/A | N/A | 500,000 | 614,000 |
| TOTAL | $426,542 | $0 | $N/A | $10,073,000 | $8,753,000 |
| Non-Current Assets | |||||
| PPE Net | 121,435 | 0 | N/A | 5,404,000 | 4,986,000 |
| Investments And Advances | 103,124 | 0 | 0 | 3,347,000 | 2,090,000 |
| Intangibles | 5,151 | 0 | 0 | 2,598,000 | 2,745,000 |
| Other Non-Current Assets | 18,901 | 0 | 0 | 365,000 | 366,000 |
| TOTAL | $248,611 | $N/A | $N/A | $11,714,000 | $10,187,000 |
| Total Assets | $675,153 | $0 | $N/A | $21,787,000 | $18,940,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,893 | 0 | 0 | 228,000 | 420,000 |
| Accrued Expenses | 30,505 | 0 | N/A | N/A | 776,000 |
| TOTAL | $73,221 | $0 | $N/A | $3,095,000 | $3,918,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | N/A | 2,329,000 | 2,402,000 |
| Deferred Revenues | 28,823 | N/A | N/A | 88,000 | 73,000 |
| Other Non-Current Liabilities | 3,146 | 530 | 0 | 248,000 | 297,000 |
| TOTAL | $131,880 | $N/A | $N/A | $3,021,000 | $3,117,000 |
| Total Liabilities | $205,101 | $0 | $N/A | $6,116,000 | $7,035,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 1,053,414 | 1,053,124 |
| Common Shares | 129 | 0 | N/A | 21,000 | 21,000 |
| Retained earnings | -467,878 | 0 | N/A | 3,482,000 | 992,000 |
| Other shareholders' equity | 8,676 | 0 | 0 | 124,000 | 197,000 |
| TOTAL | $470,052 | $0 | $N/A | $15,671,000 | $11,905,000 |
| Total Liabilities And Equity | $675,153 | $0 | $0 | $21,787,000 | $18,940,000 |